EQUITY RESEARCH MEMO

Well Pharma Medical Research

Generated 5/3/2026

Executive Summary

Conviction (model self-assessment)60/100

Well Pharma Medical Research (WPMR) is a private, multi-specialty clinical research site organization headquartered in Miami, Florida. Founded in 2006 and led by Dr. Eddie Armas, WPMR conducts Phase I through IV clinical trials across various therapeutic areas for pharmaceutical sponsors and CROs. Leveraging its long-standing presence in the South Florida research ecosystem, the company has built a reputation for patient recruitment and trial execution. While facing competition from larger SROs, WPMR's flexibility and seasoned investigator network position it to capitalize on growing demand for decentralized and site-centric trials. The company's outlook is tied to its ability to secure new contracts and expand into high-growth indications.

Upcoming Catalysts (preview)

  • Q3 2026Award of New Phase II/III Clinical Trial Contracts70% success
  • Q4 2026Expansion into Neurology or Rare Disease Trials50% success
  • H2 2026Strategic Partnership with a Top CRO or Sponsor60% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)